Perino, AlessiaDemagny, Hadrien Charles EdouardSchoonjans, Kristina2024-07-032024-07-032024-07-032024-05-2310.1016/j.cell.2024.04.020https://infoscience.epfl.ch/handle/20.500.14299/209046WOS:001246309100001In this issue of Cell, Nie and co-authors report that the microbe-derived bile acid (BA) 3-succinylated cholic acid protects against the progression of metabolic dysfunction-associated liver disease. Intriguingly, its protective mechanism does not involve traditional BA signaling pathways but is instead linked to the proliferation of the commensal microbe Akkermansia muciniphila.enLife Sciences & Biomedicinetext::journal::journal article::research article